Progesterone
Product Images NDC 0591-3128

2 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 0591-3128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Progesterone Structural Formula. (Progesterone Injection 1)

Progesterone Structural Formula. (Progesterone Injection 1)
Chemical structure diagram of progesterone showing its steroid skeleton with three six-membered rings and one five-membered ring, including methyl (CH3) groups and ketone (CO) functional groups.*
FDA Label Image

Ndc 0591-3128-79 Carton 10 mL Multiple Dose Vial 500 mg/10 mL (50 mg/ml) (Progesterone Injection 2)

Ndc 0591-3128-79 Carton 10 mL Multiple Dose Vial 500 mg/10 mL (50 mg/ml) (Progesterone Injection 2)
Packaging label for PROGESTERONE Injection USP 500 mg/10 mL (50 mg/mL) by Actavis Pharma, Inc. The label indicates it is for intramuscular use only and comes in a multiple-dose vial containing 10 mL. The label includes barcode, storage instructions, and mentions the product is sterile with specific preservatives and solvents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.